The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PKM2 and CD44 tumoral expression to predict the effectiveness of front-line paclitaxel and carboplatin chemotherapy in epithelial ovarian cancer.
 
Chara Papadaki
No Relationships to Disclose
 
Spyros Pontikakis
No Relationships to Disclose
 
Eleni Lagoudaki
No Relationships to Disclose
 
Maria Trypaki
No Relationships to Disclose
 
Filippos Koinis
No Relationships to Disclose
 
Maria Tzardi
No Relationships to Disclose
 
Linda Giannikaki
No Relationships to Disclose
 
Maria Sfakianaki
No Relationships to Disclose
 
Antonia Kalykaki
No Relationships to Disclose
 
Dimitrios Mavroudis
No Relationships to Disclose
 
Vassilis Georgoulias
Honoraria - Astellas Pharma; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Novartis; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Boehringer Ingelheim; GlaxoSmithKline; Janssen-Cilag; Novartis; Sanofi
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Novartis (Inst); Sanofi (Inst)
 
Ioannis Souglakos
No Relationships to Disclose